1. The metabolism of aflatoxin B1 in vitro was examined in rat liver microsomal preparations. 2. H.p.l.c. (high-performance liquid-chromatographic) systems were used. A silica column was used to separate non-polar metabolites. A system utilizing a reversedphase column which separates both polar and non-polar metabolites was also developed.
Aflatoxin B1, the potent hepatotoxin and hepatocarcinogen, is metabolized by rat liver microsomal enzymes to a variety of metabolites, including phenols, hydroxy compounds and probably an epoxide (Scheme 1). The epoxide has not yet been isolated and it is presumed to undergo further conversion either metabolic or non-enzymic to form a dihydrodiol (for review see Campbell & Hayes, 1976) . The only major non-microsomal route of metabolism reported is reduction to aflatoxicol, which is mediated by the cytosolic fraction. This range of metabolites reflects the existence in hepatocytes of diverse metabolic pathways. Considering these alternative pathways of metabolism in terms of detoxification or activation of aflatoxin B1, the biological potencies of the non-polar chloroformsoluble metabolites, except for aflatoxin M1, all appear to be less than that of the parent compounds and so may be considered detoxication products (Campbell & Hayes, 1976 ). Aflatoxin M1 is as acutely toxic to rats as aflatoxin B1, but has a very much smaller carcinogenic capacity (Wogan & Paglialunga, 1974) . The production of 2,3-dihydro-2,3-dihydroxyaflatoxin B1 (aflatoxin B1 2,3-dihydroAbbreviation used: h.p.l.c., high-performance liquid chromatography.
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Vol. 174 diol), which has been reported to degrade spontaneously in Tris/HCI buffer, pH7-8, to polar chloroform-insoluble products (Garner, 1973a) , could reflect a detoxifying hydrase reaction subsequent to the primary activation of aflatoxin B1 by epoxidation. The formation of the dihydrodiol may therefore indicate the aflatoxin B1-activating capacity of the microsomal preparation. Most studies of afiatoxin B1 metabolism to date have involved examinations of the chloroform-soluble non-polar metabolites on t.l.c. or paper chromatograms (Campbell & Hayes, 1976) . These studies, however, are time-consuming and difficulties arise because of the instability of some of the metabolites. H.p.l.c. offers many advantages for examination of the metabolism of aflatoxin Bi. Quantitative as well as qualitative data could be obtained in a short period of time. Although several authors have published h.p.l.c. techniques for separating aflatoxins [princi- pally the parent aflatoxins B1, B2, G1 and G2 (e.g. Pons, 1976; Garner, 1975) ], the use of these systems in actual metabolic or diagnostic studies has so far been limited Unger et al., 1977) .
Furthermore, all these studies have utilized silica columns to examine non-polar metabolites of aflatoxin B1, although it is known that a large percentage of the microsomal metabolism of this compound results in polar water-soluble compounds (Campbell & Hayes, 1976) . In those few studies in which the production of polar metabolites has been compared with metabolism to non-polar metabolites in the same microsomal preparations, the extent of formation of the polar compounds has been assessed by determining the fraction of the total label remaining in the aqueous phase after the extraction of metabolites of labelled aflatoxin B1 with chloroform; the individual polar components have not been resolved (Roebuck & Wogan, 1977; Faris & Hayes, 1975) . In other studies a different technique has been used. After microsomal metabolism of aflatoxin B1, the non-polar compounds have been separated and estimated by t.l.c. The activation of aflatoxin B1 by these same microsomal preparations has been assessed in parallel experiments in which the binding of labelled aflatoxin metabolites to DNA has been measured (Gurtoo & Motycka, 1976) Hsieh & Mateles (1971) as modified by Garner (1973b After confirmation of the identity of aflatoxins Q1 and M1 produced in microsomal incubations in vitro by reference to the authentic standards, these compounds were purified by h.p.l.c. and preparative t.l.c. and subsequently used as substrates in the metabolism studies.
Aflatoxicol was prepared by metabolism of aflatoxin B1 by the 1000OOg supernatant prepared from homogenates of chicken liver by the method of Patterson & Roberts (1971) and also by the reduction of aflatoxin B1 with NaBH4 as described by Garner et al. (1972) . Aflatoxin B2a was prepared by refluxing aflatoxin B1 with 0.03M-citric acid for 4h [Ciegler & Peterson (1968) as modified by Garner et al. (1972) ].
Aflatoxin 2,3-dihydrodiol was prepared from aflatoxin B1 by reaction of aflatoxin B1 with m-chloroperbenzoic acid in dichloromethane and subsequent hydrolysis with methanolic KOH (Garner, 1973a) . As reported by Garner (1973a) this compound spontaneously degraded in the presence of the Tris/HCI buffer, pH 7-8, which was used in the metabolic incubations, forming a water-soluble fluorescent derivative. The identity of all these products was confirmed by comparing their u.v. spectra and t.l.c. behaviour with published data.
Microsomal metabolism
Incubations, with washed microsomal fractions prepared as described above, were carried out in a shaking water bath at 37°C under 100% oxygen. Routinely the incubations were carried out in 15ml thick-walled test tubes set at an angle in the shaking bath to aid shaking the incubation medium, which contained the following: 50jumol of KCI, 150,umol of Tris/HC1, pH7.4, 12.5,umol of MgCI2, 0.4ml of microsomal suspension (normally containing approx. 4mg of protein in 150mM-KCI), 0.5 unit of glucose 6-phosphate dehydrogenase, 10,umol of glucose 6-phosphate, 0.75,umol of NADP+ and 20,u1 of dimethyl sulphoxide alone or containing 40,ug (128 nmol) of aflatoxin B1 in a total volume of 1.89 ml. Tubes were preincubated at 37°C in the bath for 5min before the addition of aflatoxin B1 or other aflatoxin substrates. In those experiments in which the metabolism of aflatoxin B1 metabolites was examined, the incubations were scaled down to a total of 0.94ml. All the other constituents of the incubations were decreased proportionally, except for aflatoxin B1 or other aflatoxin substrates, which were added at the level of 10,ug per incubation flask.
Upon completion of the incubation period, in those experiments in which only the non-polar chloroform-soluble metabolites were to be examined, 1 ml of ice-cold chloroform was added to stop the incubation and the contents were thoroughly mixed by using a Vortex mixer. Tubes were stored in ice for 30min with additional Vortex-mixing at 10min intervals. The tubes were then centrifuged at 2000 rev./min in an MSE 4L centrifuge for 15min at 4°C to separate the aqueous and organic phases. The precipitated protein was located at the interface. The chloroform layer was carefully removed and the aqueous phase together with the precipitated protein was re-extracted twice with further 1 ml portions of ice-cold chloroform. The combined chloroform extracts were blown to dryness at room temperature in a stream of oxygen-free nitrogen. The dry residues were redissolved in 200-500,ul of chloroform, and samples used for h.p.l.c. and t.l.c. analysis.
In experiments in which non-polar and polar metabolites were examined, metabolism was stopped by adding 1 ml of ice-cold methanol and the contents of the tube were thoroughly mixed by using a Vortex mixer. Internal standards could be added at this stage. Tubes were stored in ice for 30min with remixing, in the Vortex mixer, at 10min intervals. The precipitated protein was removed by centrifuging in an MSE Mistral 4L centrifuge at 2000 rev./ min (1000g) for 15min, at 4°C. The supernatant was removed and the pellet washed twice-with further 1 ml portions of ice-cold methanol, followed by centrifugation [2000rev./min for 15min (1000g)]. The combined supernatants, in 15ml thick-walled tubes, were reduced in volume at 37°C in a stream of oxygen-free nitrogen, until the volume indicated that most of the alcohol had been removed. The remaining solution was then freeze-dried overnight in the same tubes in a type SB3 freeze-drier obtained from Chem Lab Instruments, Hornchurch, Essex, U.K., fitted with a manifold. Ice-cold methanol (1 ml) was added to the freeze-dried residues and the contents were thoroughly mixed on a Vortex mixer. The tubes were centrifuged at 2000rev./min (1000g) in an MSE Mistral 4 L centrifuge set at -10°C for 1 h. The supernatants were carefully removed and transferred to small glass vials fitted with plastic caps. The residues were washed twice with further 0.5ml portions of ice-cold methanol, thoroughly mixed on the Vortex mixer and centrifuged at 2000rev./min (lOOOg) at -10°C for 30min. The combined supernatants were evaporated to dryness in a stream of oxygen-free nitrogen, the vials being held above a 37°C water bath. The residues were dissolved in 200,1 of methanol and samples used for h.p.l.c. or t.l.c. analysis. The salts carried over from the original incubation media were largely left behind after thi s methanol-extraction procedure.
H.p.l.c. analysis
The apparatus used was a Du Pont 830 liquid chromatograph fitted with an 838 gradient elution accessory, an 837 absorption detector and a Rheodyne 7120 syringe loading sample injector. The apparatus was connected to a Kontron series 1100 chart recorder fitted with an event marker. In those experiments utilizing [14C]aflatoxin B1, the h.p.l.c.
effluent was fractionated by connection to a Gilson
Microcol TDC8 fraction collector [Gilson Medical Electronics (France) Ltd.]. Chloroform extracts were chromatographed on a Du Pont Zorbax-SIL column (25cmx2.1mm internal diameter). An isocratic elution system was used, with chloroform/dichloromethane (1:1, v/v, with or without 1 % propan-2-ol) as solvent (Pons, 1976) . The apparatus was operated at a constant column pressure of 13.78 MPa, which gave a flow rate of 0.45 mli/min.
The following technique was developed for examining polar and non-polar metabolites together.
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The samples, dissolved in methanol, were chromatographed on a Du Pont Zorbax-ODS column (25 cm x 2.1mm internal diameter). Elution was by a linear gradient of 10-60% methanol in water over 40min. Phosphoric acid at a final concentration of 0.01 % was added to both primary and secondary solvents. This avoided changes in the pH during elution and resulted in a better resolution of aflatoxins M1 and Ql. The apparatus was operated at a column pressure of 20.67MPa, giving an initial flow rate of 0.48 ml/ min, which increased to 0.55 ml/min during the course of elution. The column chamber was thermostatically controlled at 37°C. Non-polar metabolites were chromatographed on silica-gel G t.l.c. plates, with chloroform/acetone (9: 1, v/v) as the developing solvent. The polar metabolites, immobile in the above solvent, were developed in chloroform/methanol (4: 1, v/v). When samples containing both polar and non-polar metabolites were examined by t.l.c., the above two solvent systems were used sequentially on the same plates. form/dichloromethane (1:1, v/v) was used for the separation given in Fig. l(a) , which is similar to that described by Pons (1976) and Garner (1975) except that we did not use solvents saturated with water. This improved the reproducibility of the separations. Difficulties with water-saturated solvents have been reported by Hsieh et al. (1976) . Our system separated the parent aflatoxins in the order Bl, G1, B2 and G2 instead of B1, B2, G1 and G2 in the system used by Pons (1976) and Garner (1975) . Line,ar detector responses for recovery of aflatoxin Bl were obtained for both peak area and peak height.
To identify the major non-polar metabolites, microsomal incubations were carried out for 30min as described in the Materials and Methods section. Samples were extracted with chloroform and chromatographed in t.l.c. and silica h.p.l.c. systems. The results of the t.l.c. separations are given in Table 1 . Fluorescence was normally detected only at the locations corresponding to the RF values of aflatoxins B1, M1 and Ql. In only a few experiments was a trace of fluorescence detected at the RF Of aflatoxin P1. The presence of aflatoxin B2a and aflatoxicol was not detected. To elute aflatoxin M1 and Q1 standards from the Zorbax-Sil h.p.l.c. column it was necessary to add 1% propan-2-ol to the eluting solvent. The resulting separation (Fig. lb) shows that the resolution of aflatoxins B1, G1, B2 and G2 was largely lost in achieving a reasonably short retention time for aflatoxin Ml.
When a chloroform extract of a microsomal incubation of aflatoxin B1, incubated either in the presence or absence of NADPH, was injected on to the Zorbax-Sil column and subsequently eluted with the chloroform/dichloromethane/propanol solvent, the results indicated in Fig. 2 were obtained. These results confirmed the t.l.c. findings that in the presence of NADPH aflatoxins M1 and Q1 were the principal non-polar metabolites produced by microsomal metabolism of aflatoxin B1. No conversion into aflatoxins M1 and Q1 occurred in the absence of NADPH. The identities of the compounds were further checked by adding small quantities of authentic aflatoxin M1 or Q1 to the extracts before injection and confirming increases in heights and areas of the appropriate detector peaks.
Time course of aflatoxin B1 metabolism. Aflatoxin B%-metabolizing incubations were carried out with microsomal fractions prepared from either control rats or animals pretreated with phenobarbitone in drinking water (0.1 %, w/v, for 2 weeks). The time course of the metabolism was examined with the h.p.l.c. silica column system, and the results are given in Fig. 3(a) . Under the conditions used, metabolism of aflatoxin B1 virtually ceased within 30min of incubation with microsomal fractions from either control or phenobarbitone-pretreated rats. The H.p.l.c. conditions were as in Fig. 1(b Zorbax-ODS column.
The identity of the compounds present in the peaks was confirmed by coincidence on t.l.c. plates and also by additions of the individual authentic compounds to the metabolite extracts before h.p.l.c. The degradation product of aflatoxin B, 2,3-dihydrodiol was present in the extracts. The formation of these compounds by microsomal metabolism of aflatoxin Fraction no. are summarized in Table 3 . Comparing the results given in Fig. 3 , obtained by using the silica column, with those in Table 3 , obtained by using the reversedphase column, shows that both techniques indicated that a 4-5-fold increase in production of aflatoxin Q1 and a 1-2-fold increase in aflatoxin M1 production resulted from phenobarbitone pretreatment of the animals. In addition the Zorbax-ODS technique also indicated that a 4-5-fold increase in aflatoxin Bl 2,3-dihydrodiol production resulted from the pretreatment of the animals with phenobarbitone.
Metabolism of aflatoxins Ml, Qt and Pl. In view of the possible significance of the production of more polar metabolites in terms of the activation of aftatoxin B, (Campbell & Hayes, 1976) metabolite was found, but, in addition, a metabolite having the same retention time as aflatoxin B1 appeared as well as small amounts of more polar metabolites. The identity of the former metabolite as aflatoxin B1 was confirmed by co-chromatography with authentic aflatoxin B1.
Lack of effect of adding reduced glutathione or 1 ,2-epoxy-3,3,3-trichloropropane to incubations. It appeared possible that a strongly electrophilic epoxide and its subsequent hydration by epoxide hydrase activity could be involved in the production of the dihydrodiol. Therefore in some experiments the nucleophilic compounds reduced glutathione (I mM) and the epoxide hydrase inhibitor 1,2-epoxy-3,3,3-trichloropropane (0.5mM) were added to incubations with the standard incubation procedures and aflatoxin Bl. Microsomal preparations from phenobarbitone-pretreated rats were used because of their greater metabolizing capacity. No differences in either the pattern or the amounts of metabolites resulted from adding these compounds to the incubation medium.
Discussion
Our data on the principal non-polar chloroformsoluble metabolites of aflatoxin B1 produced by rat liver microsomal preparations obtained with both silica and reversed-phase h.p.l.c. columns in the present study, and their relative abundances, are generally in agreement with reports of other workers. In agreement with Dahms & Gurtoo (1976) and Roebuck & Wogan (1977) , who used t.l.c. methods, we found approximately twice as much aflatoxin Qi as aflatoxin Ml to be formed in the incubations of microsomal fractions isolated from control rats. In our experiments, however, pretreatment with phenobarbitone resulted not only in a greatly increased rate and extent of overall metabolism of aflatoxin B1, but also in a disproportionate increase in aflatoxin Q1 compared with aflatoxin M1. This result is in contrast with that of Dahms & Gurtoo (1976) , who found in their experiments that the relative proportions of aflatoxins Q, and M1 in the medium after microsomal incubations in vitro did not alter as a result of pretreating the animals with phenobarbitone. The finding in our experiments that the production of aflatoxin Q, by microsomal fractions increased by 4-5-fold as a result of pretreating the rats with phenobarbitone, whereas the production of aflatoxin M1 was increased by 1-2-fold, indicates that the different metabolic pathways leading to formation of these two metabolites, although both presumably mediated by cytochrome P-450 since they are both stimulated by phenobarbitone pretreatment, are not so tightly integrated that stimulation of the metabolic formation of one compound automatically results in a proportionate stimulation in the production of the other. Multiple forms of cytochrome P-450 with different substrate specificities have been reported (Lu & Levin, 1974) . It was also found that pretreatment with phenobarbitone increased the formation of the compound formed by the spontaneous degradation of aflatoxin B1 2,3-dihydrodiol in neutral Tris/HCl buffer to approximately the same extent as the increase in production of aflatoxin Q, but not aflatoxin M,. In agreement with Roebuck & Wogan (1977) and Dahms & Gurtoo (1976) , we found aflatoxin P1 production to be at or below the minimum level of detection. Aflatoxin B2a and aflatoxicol were not found in the medium after microsomal incubations. Schabort & Steyn (1969) (Garner et al., 1972) , and also by the inhibition of RNA synthesis in hepatic nuclei in vitro (Neal & Godoy, 1976) . However, the results obtained when 1,2-epoxy-3,3,3-trichloropropane or reduced glutathione were added to the incubations, appear to be in conflict with the proposal that the primary activation of aflatoxin B, depends on the formation of a strongly electrophilic epoxide, which is subsequently converted into a dihydrodiol via epoxide hydrase. Using benzopyrene in microsomal metabolizing systems, Freundenthal et at. (1975) found that the addition of 0.05 mM-1 ,2-epoxy-3,3,3-trichloropropane to the incubation system resulted in almost complete inhibition of the production of benzopyrene dihydrodiols and more polar metabolites, presumably by inhibiting the activity of epoxide hydrase, and a striking increase in the production of less polar metabolites. A similar result might have been expected in the present study when 1,2-epoxy-3,3,3-trichloropropane at the same concentration as that used by Freundenthal et al.
(1975) (0.05mM) was added to the aflatoxin B,-metabolizing microsomal system. However, if aflatoxin B, is first activated to form a 2,3-epoxide and then is further converted to form the 2,3-dihydrodiol, our results would indicate that this latter step is either non-enzymic or else takes place in a system not susceptible to inhibition by 1,2-epoxy-3,3,3-trichloropropane. Furthermore the nucleophile reduced glutathione did not, as might have been expected, decrease the production of the 2,3-dihydrodiol by reacting with an electrophilic metabolite of aflatoxin B1 (Guengerich, 1977) . Such unexpected behaviour in aflatoxin B,-metabolizing systems in vitro has been previously reported by Garner & Wright (1973), who found that in the presence of a range of nucleo-849 philic compounds at the concentration used in this present study (1mM) there was no decrease in the lethality of the microsomally formed aflatoxin B1 metabolite in vitro. We have found similar results on examining the formation in vitro of aflatoxin B1 metabolites that are capable of inhibiting nucleic acid synthesis in isolated nuclei (G. E. Neal & D. J. Judah, unpublished results). It would appear therefore that the mechanism of the activation of aflatoxin B1 by microsomal systems needs further attention and the reverse-phase h.p.l.c. system described in this paper could facilitate such studies.
In view of the possible importance of metabolic activation of aflatoxin B1 to its biological potency the possible further metabolism of the aflatoxin B1 metabolites aflatoxins P1, M1 or Qi would be of interest. Aflatoxins P1 and Qi have low biological potencies, whereas aflatoxin Ml is as acutely toxic in many species as aflatoxin B1, but has a much diminished carcinogenic potential (Wogan & Paglialunga, 1974) .
4flatoxin M1
If the toxicities of the aflatoxins are mediated via microsomal activation followed by nuclear binding, and the extent of the microsomal activation is indicated by the amount of polar metabolites formed, it is difficult to see from the present results how the acute toxicities of aflatoxins B1 and Ml could be similar. Aflatoxin M1 underwent minimal metabolism and formed only very small amounts of a compound which was eluted at approximately the same retention time as the degradation product of aflatoxin B1 2,3-dihydrodiol. At present little is known about the nuclear binding of metabolites of aflatoxin Bl. It has been shown (Neal & Godoy, 1976 ) that aflatoxin Ml requires activation by microsomal preparations in order to inhibit nuclear RNA synthesis in isolated nuclei; The possibility still exists, however, that in both aflatoxin M1 and B1 the nuclear binding is significant only in terms of the carcinogenic response and that binding to various subcellular organelles, for example, rough endoplasmic reticulum and smooth endoplasmic reticulum (Williams et al., 1973) , which does not depend on metabolism, could be responsible for the acutely toxic reaction.
Aflatoxin P1
Aflatoxin P1 was not metabolized by our microsomal systems. The absence of this metabolite from the incubations therefore cannot be explained in terms of its rapid further metabolism. This result is somewhat puzzling, since Wogan et al. (1967) metabolic pathway in rats in vivo. In contrast with rat liver microsomal preparations, aflatoxin P1 has been reported to be a major metabolite when aflatoxin B1 is metabolized by mouse microsomal preparations (Dahms & Gurtoo, 1976) . The reason for this discrepancy between the results obtained in vivo and in vitro in rats requires further study.
Aflatoxin Q, Aflatoxin Q, was stable in the incubation medium in the absence of microsomal preparation. In the presence of microsomal fraction and absence of NADPH, however, there was metabolism of aflatoxin Q,. It is of interest that, in the presence of NADPH, metabolism of aflatoxin Q, to aflatoxin B1
and also to more polar metabolites with similar retention times to those seen in aflatoxin B1 incubations was observed. It has been suggested that the limited mutagenicity of aflatoxin Qi (a major metabolite in incubations in vitro with human and monkey microsomal preparations; Roebuck & Wogan, 1977) may reflect a requirement for its prior conversion into aflatoxin B1 (Wong & Hsieh, 1976) .
The results ofthe present study would be in agreement with the feasibility of this reaction. It is noteworthy that the limited production of polar metabolites observed when aflatoxin Ml was incubated was not accompanied by the appearance of aflatoxin B1.
In conclusion, the reversed-phase h.p.l.c. system described in this paper has much to recommend it as a means of evaluating the spectrum of aflatoxin metabolites, polar and non-polar, present in the same extract.
